Filing Details

Accession Number:
0000899243-22-028032
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-08 21:33:51
Reporting Period:
2022-08-04
Accepted Time:
2022-08-08 21:33:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1837014 Smartrent Inc. SMRT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1295402 T Enrique Salem C/o Bain Capital Venture Investors,
200 Clarendon Street
Boston MA 02116
No No Yes No
1309469 Bain Capital Venture Investors, Llc 200 Clarendon Street
Boston MA 02116
No No Yes No
1708763 Ajay Agarwal C/o Bain Capital Venture Investors,
200 Clarendon Street
Boston MA 02116
No No Yes No
1756817 Bain Capital Venture Fund 2019, L.p. 200 Clarendon Street
Boston MA 02116
No No Yes No
1758684 Bcv 2019-Md Primary, L.p. 200 Clarendon Street
Boston MA 02116
No No Yes No
1859012 Bcip Venture Associates Ii-B, Lp 200 Clarendon Street
Boston MA 02116
No No Yes No
1859026 Bcip Venture Associates Ii, L.p. 200 Clarendon Street
Boston MA 02116
No No Yes No
1859037 Bain Capital Venture Investors 2019, Llc 200 Clarendon Street
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2022-08-04 69,098 $5.61 19,996,739 No 4 S Indirect See footnotes
Class A Common Stock Disposition 2022-08-05 77,042 $5.70 19,919,697 No 4 S Indirect See footnotes
Class A Common Stock Disposition 2022-08-08 75,100 $5.57 19,844,597 No 4 S Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnotes
No 4 S Indirect See footnotes
No 4 S Indirect See footnotes
Footnotes
  1. Bain Capital Venture Investors, LLC ("BCVI") is the manager of Bain Capital Venture Investors 2019, LLC ("BCVI 2019"), which is the general partner of each of Bain Capital Venture Fund 2019, L.P. ("BCV Fund 2019") and BCV 2019-MD Primary, L.P. ("BCV MD Primary"). As a result, BCVI 2019 may be deemed to share voting and dispositive power with respect to the shares of the Issuer's Class A Common Stock held by BCV Fund 2019 and BCV MD Primary. BCVI 2019 disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. On August 4, 2022, August 5, 2022 and August 8, 2022, BCV Fund 2019 sold 60,166, 67,083 and 65,392 shares of the Issuer's Class A Common Stock, respectively, and BCV MD Primary sold 2,314, 2,580 and 2,515 shares of the Issuer's Class A Common Stock, respectively. Following such sales, BCV Fund 2019 and BCV MD Primary held 17,279,288 and 664,595 shares of the Issuer's Class A Common Stock, respectively.
  2. Boylston Coinvestors, LLC is the general partner of each of BCIP Venture Associates II, L.P. ("BCIP Venture II") and BCIP Venture Associates II-B, LP ("BCIP Venture II-B" and, together with BCV Fund 2019, BCV MD Primary and BCIP Venture II, the "Bain Capital Venture Entities"). On August 4, 2022, August 5, 2022 and August 8, 2022, BCIP Venture II sold 6,121, 6,825 and 6,653 shares of the Issuer's Class A Common Stock, respectively, and BCIP Venture II-B sold 497, 554 and 540 shares of the Issuer's Class A Common Stock, respectively. Following such sales, BCIP Venture II and BCIP Venture II-B held 1,757,901 and 142,813 shares of the Issuer's Class A Common Stock, respectively.
  3. The governance, investment strategy and decision-making process with respect to the investments held by the Bain Capital Venture Entities is directed by the Executive Committee of BCVI, which consists of Enrique Salem and Ajay Agarwal. As a result, BCVI and Messrs. Salem and Agarwal may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Venture Entities. BCVI and Messrs. Salem and Agarwal disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.49 to $5.775, inclusive. The reporting persons undertake to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (6) to this Form 4.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.51 to $5.81, inclusive.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.45 to $5.90, inclusive.